Chlojaponilactone B Attenuates THP-1 Macrophage Pyroptosis by Inhibiting the TLR/MyD88/NF-κB Pathway
Pharmaceuticals · 21.03.2024 · 17 (3) · 402
DOI: 10.3390/ph17030402 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceuticals, online erschienen am 21.03.2024. Verfasst von Qiyin Wen und 10 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, China. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Yunnan Science and Technology Talents and Platform Program.
Abstract (Originalsprache)
Pyroptosis, an innate immune response, plays a crucial role in the pathological process of inflammatory diseases. Although pyroptosis blockade is considered a potential therapeutic strategy, no ideal candidate drug has been identified. The natural product Chojaponilactone B (CJB) has demonstrated anti-inflammatory effects, but its role in macrophage pyroptosis has not been studied. This study aimed to investigate the effect and mechanism of CJB in inhibiting macrophage pyroptosis. Using an LPS/ATP-induced THP-1 macrophage pyroptosis model, we found that CJB significantly inhibited pyroptosis and reduced the levels of NLRP3, caspase 1, N-GSDMD, and inflammatory cytokines IL-1β and IL-18. RNA sequencing analysis revealed that CJB interfered with LPS/ATP-induced THP-1 macrophage gene expression, suggesting involvement in anti-inflammatory and anti-pyroptotic signaling pathways. Additionally, CJB suppressed LPS/ATP-induced elevations in TLRs, MyD88, pro-IL-1β, and NF-κB and blocked NF-κB p65 nuclear translocation. In summary, CJB inhibits NLRP3 activation and macrophage pyroptosis through the TLR/MyD88/NF-κB pathway, providing important evidence for its development as a potential drug for treating pyroptosis-related inflammatory diseases.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, China.
- Yunnan Key Laboratory of Southern Medicine Utilization, Yunnan Branch Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences, Jinghong 666100, China.
ORCID-Profile: Zhimin Zhao
Förderung
- National Natural Science Foundation of China
- Yunnan Science and Technology Talents and Platform Program
Zitieren
APA
Wen, Q., Zhan, B., Jin, L., Peng, Z., Liu, J., Zhu, L., Yang, D., Xu, X., Zhang, L., Li, G., & Zhao, Z. (2024). Chlojaponilactone B Attenuates THP-1 Macrophage Pyroptosis by Inhibiting the TLR/MyD88/NF-κB Pathway. Pharmaceuticals, 17(3), 402. https://doi.org/10.3390/ph17030402
Vancouver
Wen Q, Zhan B, Jin L, Peng Z, Liu J, Zhu L, et al. Chlojaponilactone B Attenuates THP-1 Macrophage Pyroptosis by Inhibiting the TLR/MyD88/NF-κB Pathway. Pharmaceuticals. 2024;17(3):402. doi:10.3390/ph17030402
BibTeX
@article{Wen2024,
author = {Wen, Qiyin and Zhan, Bingjinfeng and Jin, Lu and Peng, Zijing and Liu, Ju and Zhu, Longping and Yang, Depo and Xu, Xinjun and Zhang, Lixia and Li, Ge and Zhao, Zhimin},
title = {Chlojaponilactone B Attenuates THP-1 Macrophage Pyroptosis by Inhibiting the TLR/MyD88/NF-κB Pathway},
journal = {Pharmaceuticals},
year = {2024},
volume = {17},
number = {3},
pages = {402},
doi = {10.3390/ph17030402}
}
EUVIMED